The FISH - CLL Panel Test, offered by DNA Labs UAE, is a specialized diagnostic tool designed to detect chromosomal abnormalities in patients with Chronic Lymphocytic Leukemia (CLL). This test utilizes Fluorescence In Situ Hybridization (FISH) technology to identify specific genetic markers associated with CLL, providing valuable information that can influence treatment decisions and prognostic assessments. Priced at 1900 AED, the FISH - CLL Panel Test is a critical resource for clinicians in the management and understanding of CLL, offering insights into the genetic landscape of the disease that traditional diagnostic methods may not reveal.
The FISH (Fluorescence In Situ Hybridization) - EGFR Gene Amplification Test is a sophisticated diagnostic procedure available at DNA Labs UAE, designed to detect amplifications of the EGFR gene within a patient's DNA. EGFR, or Epidermal Growth Factor Receptor, plays a crucial role in cell growth and division. Its amplification can be indicative of various types of cancers, including lung, breast, and colorectal cancers, making this test a vital tool in the diagnosis and management of these conditions.
The test employs fluorescent probes to bind to specific DNA sequences related to the EGFR gene. By applying these probes to cells or tissue samples, the test can highlight the presence of EGFR gene amplifications through fluorescence microscopy. This method allows for a highly sensitive and specific analysis of the genetic material, providing clinicians with critical information that can guide treatment decisions, particularly in selecting targeted therapies for cancer patients.
At DNA Labs UAE, the FISH - EGFR Gene Amplification Test is offered at a cost of 2010 AED. The price reflects the technical sophistication and the detailed, personalized insights the test provides into a patient's genetic profile. With its state-of-the-art facilities and expert staff, DNA Labs UAE ensures accurate, reliable results for this essential diagnostic test, supporting effective, personalized treatment plans for patients facing EGFR-related conditions.
The "FISH - Synovial Sarcoma SS18 SYT 18q11.2 Gene Rearrangement Test" is a diagnostic tool used to identify the specific genetic alteration associated with synovial sarcoma, a type of cancer that usually occurs near the joints of the arm, neck, or leg. This test employs Fluorescence In Situ Hybridization (FISH) technology to detect the rearrangement of the SS18 (formerly known as SYT) gene located on chromosome 18 at position q11.2. This gene rearrangement is a hallmark of synovial sarcoma and is critical for accurate diagnosis and treatment planning.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test is priced at 2010 AED. The lab utilizes advanced molecular techniques to provide precise results, which are crucial for determining the appropriate therapeutic approach and assessing prognosis. By identifying the presence of the SS18 SYT gene rearrangement, healthcare providers can confirm a diagnosis of synovial sarcoma, enabling targeted treatment strategies and potentially improving patient outcomes.
The Hepatitis C Monitoring Panel Test is a comprehensive diagnostic tool used to assess and monitor the progression or treatment response of Hepatitis C virus (HCV) infection. This panel typically includes a series of blood tests that measure the viral load (quantity of the virus in the blood), check for the presence of antibodies against the HCV, and sometimes assess the virus's genotype, which can influence treatment decisions. Additionally, liver function tests are often part of the panel to evaluate the impact of the virus on liver health.
At DNA Labs UAE, the cost for the Hepatitis C Monitoring Panel Test is set at 2010 AED. DNA Labs UAE is known for its state-of-the-art facilities and highly qualified staff, ensuring accurate and reliable test results. This test is crucial for individuals diagnosed with or suspected of having Hepatitis C, as it guides healthcare providers in making informed decisions regarding the best course of treatment and monitoring the effectiveness of therapy over time.
The "Interleukin-6 (IL-6) SARS-CoV-2 Basic Panel Test" is a specialized diagnostic assay offered by DNA Labs UAE, designed to measure the levels of Interleukin-6 (IL-6) in the blood. IL-6 is a cytokine that plays a critical role in the body's immune response to infections, including the novel coronavirus (SARS-CoV-2), which is responsible for the COVID-19 pandemic. Elevated levels of IL-6 are indicative of an inflammatory response, which can be particularly relevant in the context of severe COVID-19 cases where a cytokine storm may occur, leading to significant tissue damage and complications.
This test is crucial for clinicians to assess the severity of the infection and to make informed decisions regarding the management and treatment strategies for patients with COVID-19. It provides valuable insights into the patient's immune response and helps in identifying individuals at risk of developing severe complications, thereby facilitating timely and appropriate medical interventions.
The test is conducted at DNA Labs UAE, a reputable facility known for its state-of-the-art technology and adherence to international standards in medical diagnostics. The cost of the test is 2010 AED, reflecting the comprehensive analysis and accuracy it offers in aiding the diagnosis and management of COVID-19 patients by evaluating their immunological status through IL-6 levels.
The Thioridazine Test is a specialized diagnostic procedure aimed at measuring the levels of Thioridazine, an antipsychotic medication, in a patient's blood. This test is particularly crucial for individuals undergoing treatment with Thioridazine, as it helps in ensuring the drug is within the therapeutic range, optimizing treatment efficacy while minimizing potential side effects. Given the precise nature of this test, it is conducted in sophisticated laboratory settings such as DNA Labs UAE, a reputable facility known for its advanced diagnostic services. The cost of the Thioridazine Test at DNA Labs UAE is set at 2010 AED, reflecting the comprehensive approach and accuracy of the test in monitoring the drug's concentration. This test is essential for healthcare providers to make informed decisions regarding dosage adjustments and to monitor the patient's response to treatment, ensuring a personalized and effective therapeutic strategy.
The "Insulin Antibodies Highly Sensitive Test" is a specialized diagnostic procedure designed to detect antibodies against insulin in the blood. These antibodies can interfere with insulin action or with insulin measurements in individuals, potentially leading to conditions such as insulin resistance or autoimmune diabetes. The presence of insulin antibodies is a critical marker for understanding various diabetes-related conditions and can help in the management and treatment of patients, especially those who might be experiencing unusual blood glucose levels or have a history of autoimmune diseases.
Performed at DNA Labs UAE, a leading laboratory known for its advanced diagnostic solutions, this test offers a highly sensitive approach to detecting even low levels of insulin antibodies. Utilizing state-of-the-art technology, DNA Labs ensures precise and reliable results, contributing significantly to patient care and management strategies.
The cost of the Insulin Antibodies Highly Sensitive Test at DNA Labs UAE is set at 2010 AED. This investment covers the sophisticated techniques and equipment required to accurately identify the presence and levels of insulin antibodies, providing essential insights for healthcare providers. Patients and doctors considering this test can expect a thorough analysis, which is crucial for developing an effective treatment plan for conditions influenced by insulin antibodies.
The Tryptophan Quantitative Plasma Test is a specialized diagnostic procedure designed to accurately measure the concentration of tryptophan in the plasma. Tryptophan is an essential amino acid that plays a crucial role in various bodily functions, including the synthesis of serotonin, a neurotransmitter important for mood regulation, and melatonin, which regulates sleep. This test is particularly useful for identifying abnormalities in tryptophan levels, which can be indicative of nutritional deficiencies, metabolic disorders, or certain psychiatric conditions.
Conducted at DNA Labs UAE, a leading facility in medical diagnostics, the test offers precise and reliable results. The cost of the Tryptophan Quantitative Plasma Test is set at 2010 AED, reflecting the advanced technology and expertise required to accurately assess tryptophan levels. This test is a valuable tool for healthcare providers in diagnosing and managing conditions related to amino acid imbalances, guiding nutritional therapy, and monitoring the effectiveness of treatment plans.
The Autogen Panel Test, available at DNA Labs UAE for a cost of 2010 AED, is a comprehensive genetic screening designed to analyze an individual's DNA for various genetic markers that could indicate susceptibility to certain diseases or conditions. This state-of-the-art test is performed using a small sample of the individual's blood or saliva, which is then meticulously analyzed in the lab using advanced genomic technologies. The Autogen Panel Test is aimed at providing insights into genetic predispositions, enabling individuals to make informed decisions about their health and lifestyle. By identifying potential genetic risks early, it allows for preventive measures, personalized healthcare planning, and a better understanding of one's genetic makeup. DNA Labs UAE, with its cutting-edge facilities and expert team, ensures accuracy and confidentiality in the test results, making the Autogen Panel Test a valuable tool in the pursuit of personalized medicine and health optimization.
The Episodic Ataxia Type 1 Hotspot Test is a specialized genetic test offered by DNA Labs UAE, designed to diagnose Episodic Ataxia Type 1 (EA1), a rare neurological disorder characterized by sudden, brief episodes of ataxia (lack of muscle coordination) along with other potential symptoms such as muscle twitching and dizziness. This condition is caused by mutations in the KCNA1 gene, which plays a critical role in regulating potassium channels in the brain, essential for maintaining the normal function of nerve cells.
The test specifically targets known mutation hotspots within the KCNA1 gene, providing a focused approach to diagnosing this complex condition. By analyzing the patient's DNA sample, the test can identify mutations associated with EA1, thereby facilitating an accurate diagnosis. This is crucial for the management and treatment of symptoms, as well as for genetic counseling purposes.
DNA Labs UAE offers this cutting-edge genetic test for a cost of 1990 AED. The test represents a significant advancement in the field of genetic diagnostics, providing patients and their families with critical information about EA1 and contributing to a better understanding of the condition's underlying genetic basis. With a commitment to accuracy and reliability, DNA Labs UAE ensures that individuals undergoing the Episodic Ataxia Type 1 Hotspot Test receive comprehensive support and detailed results, paving the way for informed healthcare decisions.
